Head-to-head comparison
Curex vs No BS RX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Identical $199 pricing on both molecules, plus oral routes and nationwide reach — simple math for switchers.
$199/mo sema · $199/mo tirz
Marked down on: No brand-name access
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Desk Score
Six programs across four terms on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate promise the arithmetic actually supports.
$179/mo sema · $249/mo tirz · Verified September 2026
Marked down on: The same $409 twelve-week block appears under three different monthly rates — a $11 saving against one and a $128 saving against another, presented identically.
Curex takes this head-to-head with the higher Desk Score, 89/100 (B+) against 82/100 (B−) for No BS RX. No BS RX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Curex
89/100
B+
No BS RX
82/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Curex | No BS RX |
|---|---|---|
| Semaglutide | $199/mo$199/mo | $179/mo$179/mo month-to-month (compounded; a separate low-dose program is $140) |
| Tirzepatide | $199/mo$199/mo | $249/mo$249/mo month-to-month (compounded; a separate low-dose program is $140) |
| Coverage | All 50 states | Not listed on No BS RX's site (checked September 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who may switch between semaglutide and tirzepatide and want one predictable price for either. | Anyone who wants to compare every term and every dose level without starting an intake to see a price. |
| Desk Score | 89/100B+ | 82/100B− |
The verdict
Desk pick — CurexCurex takes this head-to-head with the higher Desk Score, 89/100 (B+) against 82/100 (B−) for No BS RX. No BS RX still holds its ground where its strengths line up with yours.
Choose Curex if…
People who may switch between semaglutide and tirzepatide and want one predictable price for either.
$199/mo sema · $199/mo tirz · All 50 states
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Choose No BS RX if…
Anyone who wants to compare every term and every dose level without starting an intake to see a price.
$179/mo sema · $249/mo tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Curex · No BS RX.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Curex
- CoreAge Rx vs No BS RX
- Curex vs Shed
- Bodybuilding Health+ vs No BS RX
- Curex vs Tyde Wellness
- Lighter You vs No BS RX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.